Notes / Company

Fischer Medical Ventures Ltd.

FISCHER BSE 524743 ISIN INE771F01041 Chemicals

Fundamentals

Market cap: ₹2,478 cr
P/E: 62.81×
ROE: 0.44%
Debt / equity: 0.18
Div yield: 0.01%
52-week range: 32.09 — 124.20

The timeline — 1 note on Fischer Medical Ventures Ltd.

May 2026

31 May 26 · 10:46 PM IST Brief

Brief · Earnings · Small cap

Fischer's consolidated profit of ₹310 cr hides a standalone loss of ₹104 cr

Full-year consolidated revenue tripled to ₹3,086 crore, but the core business lost money and Q4 swung to a ₹71 crore loss.

Verify on exchange BSE filings for FISCHER NSE filings for FISCHER